From Genetic Tests to Tailored Care: Decoding a field with big potential -- and even bigger implications
By Kelly Bothum,
Delaware Online
| 06. 01. 2010
[Quotes CGS's Jesse Reynolds]
Imagine a doctor using your genetic profile to decide which medicine to prescribe or to determine your risk for developing a life-threatening health problem. It's not a medical fantasy -- genetic tests already are used to gauge how patients will respond to certain drugs or to look for mutations in specific genes that can increase the risk for developing aggressive types of cancer.
But while the potential of so-called personalized medicine seems immense, some big questions are years away from being fully answered. Right now, researchers are still trying to understand key issues related to this next frontier of modern medicine, including how genetic profiling can help patients better understand their health risks, how medical professionals will be able to interpret results and what, if any, ethical implications arise in having this much genetic information.
"Personalized medicine is still in its infancy," said Dr. Ayyappan Rajasekaran, director of the Nemours Center for Childhood Cancer Research, which is studying biomarkers that can help identify more aggressive forms of the disease in kids. "We have a chance to do fantastic work."
At...
Related Articles
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...